https://www.indianpharmapost.com/jubilant-ingrevia-posts-q3fy23-consolidated-pat-at-rs-9153-cr-136742023-02-02T00:00:00+05:30always0.9https://www.indianpharmapost.com/hester-biosciences-q3-fy23-consolidated-net-profit-up-at-rs-1118-cr-136752023-02-02T00:00:00+05:30always0.9https://www.indianpharmapost.com/jubilants-radiopharma-business-receives-nda-approval-for-technetium-mertiatide-injection-136762023-02-02T00:00:00+05:30always0.9https://www.indianpharmapost.com/balaxi-pharmaceuticals-revenue-up-403-136772023-02-02T00:00:00+05:30always0.9https://www.indianpharmapost.com/budget-2023-24-industry-welcomes-focus-on-medical-research-and-pharma-innovation-136782023-02-02T00:00:00+05:30always0.9